News

According to the company, this novel test incorporates 10 biomarkers, two of which are proprietary, along with a proprietary algorithm to help physicians diagnose patients with irritable bowel

In 2008, Voboril, 66, retired as chairman of Greatbatch, Inc., where he served as chief executive officer from 1990 to 2006. During his tenure at Greatbatch, he led

AOS Medical Center, Glendale, California, purchased a KODAK DIRECTVIEW DR 3500 System and a PACS workstation for its orthopedic practice through Merry X-Ray, an authorized distributor. Doctors Community

Genentech, a biotechnology company, and US-based Biogen Idec have announced that a Phase III study of Rituxan plus mycophenolate mofetil and corticosteroids in patients with lupus nephritis did

Philip Stimpson, Mediwatch chief executive commented’ “We are confident that this strategically important distribution agreement will deliver a significant revenue stream. The market for point of care diagnostics

Pfizer has stopped a Phase III clinical trial of Sutent early after the drug showed significant benefit in patients with advanced pancreatic islet cell tumors, also known as

Biothera, a biotechnology company, has received approval form the German regulatory authorities to conduct two open label, multicenter, randomized Phase II clinical trials studying Imprime PGG administered in

Icagen, a biopharmaceutical company, has initiated a Phase II proof-of-concept study of senicapoc, a novel orally available small molecule inhibitor of the KCa3.1 potassium ion channel, in patients

ValiRx, a cancer therapeutics and diagnostics company, has successfully completed its first collaborative stage with Cancer Research Technology, undertaken through the company’s biopharmaceutical division ValiPharma. Trials completed under